Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × talquetamab × 30 days × Clear all

Status

Sponsor Class

Study Type

Interventional 14 Observational 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Blood Specimen Collection 18 Surveys and Questionnaires 17 Specimen Handling 11 Radiotherapy 9 Immune Checkpoint Inhibitors 8 Watchful Waiting 7 Observation 6 Interviews as Topic 6 Biopsy 6 ribociclib 4 Tissue Banks 4 Drug Therapy 4 pembrolizumab 3 lenvatinib 3 enzalutamide 3 darolutamide 3 Standard of Care 3 Magnetic Resonance Spectroscopy 3 Liquid Biopsy 3 Letrozole 3 Anastrozole 3 trametinib 2 regorafenib 2 pertuzumab 2 efgartigimod alfa 2 durvalumab 2 dabrafenib 2 atezolizumab 2 apalutamide 2 Tomography, X-Ray Computed 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06285318 2026-03-12

REALiTEC/TAL

Janssen-Cilag Ltd.

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡